Elucidating the mechanobiology of malignant brain tumors using a brain matrix-mimetic hyaluronic acid hydrogel platform

Department of Bioengineering and California Institute for Quantitative Biosciences, University of California, Berkeley, CA 94720, USA.
Biomaterials (Impact Factor: 8.56). 11/2011; 32(31):7913-23. DOI: 10.1016/j.biomaterials.2011.07.005
Source: PubMed


Glioblastoma multiforme (GBM) is a malignant brain tumor characterized by diffuse infiltration of single cells into the brain parenchyma, which is a process that relies in part on aberrant biochemical and biophysical interactions between tumor cells and the brain extracellular matrix (ECM). A major obstacle to understanding ECM regulation of GBM invasion is the absence of model matrix systems that recapitulate the distinct composition and physical structure of brain ECM while allowing independent control of adhesive ligand density, mechanics, and microstructure. To address this need, we synthesized brain-mimetic ECMs based on hyaluronic acid (HA) with a range of stiffnesses that encompasses normal and tumorigenic brain tissue and functionalized these materials with short Arg-Gly-Asp (RGD) peptides to facilitate cell adhesion. Scanning electron micrographs of the hydrogels revealed a dense, sheet-like microstructure with apparent nanoscale porosity similar to brain extracellular space. On flat hydrogel substrates, glioma cell spreading area and actin stress fiber assembly increased strongly with increasing density of RGD peptide. Increasing HA stiffness under constant RGD density produced similar trends and increased the speed of random motility. In a three-dimensional (3D) spheroid paradigm, glioma cells invaded HA hydrogels with morphological patterns distinct from those observed on flat surfaces or in 3D collagen-based ECMs but highly reminiscent of those seen in brain slices. This material system represents a brain-mimetic model ECM with tunable ligand density and stiffness amenable to investigations of the mechanobiological regulation of brain tumor progression.

Download full-text


Available from: Badriprasad Ananthanarayanan, Apr 04, 2014
  • Source
    • "The tumor stroma microenvironment comprises fibroblasts, adipocytes, inflammatory cells such as lymphocytes and macrophages and lymphatic and blood capillaries including pericytes and endothelial cells [63]. Therefore, cancer progression and metastasis depends on the crosstalk within the microenvironments [64]–[67]. "
    [Show abstract] [Hide abstract]
    ABSTRACT: Development of a physiologically relevant 3D model system for cancer research and drug development is a current challenge. We have adopted a 3D culture system based on a transglutaminase-crosslinked gelatin gel (Col-Tgel) to mimic the tumor 3D microenvironment. The system has several unique advantages over other alternatives including presenting cell-matrix interaction sites from collagen-derived peptides, geometry-initiated multicellular tumor spheroids, and metabolic gradients in the tumor microenvironment. Also it provides a controllable wide spectrum of gel stiffness for mechanical signals, and technical compatibility with imaging based screening due to its transparent properties. In addition, the Col-Tgel provides a cure-in-situ delivery vehicle for tumor xenograft formation in animals enhancing tumor cell uptake rate. Overall, this distinctive 3D system could offer a platform to more accurately mimic in vivo situations to study tumor formation and progression both in vitro and in vivo.
    PLoS ONE 08/2014; 9(8):e105616. DOI:10.1371/journal.pone.0105616 · 3.23 Impact Factor
    • "Because of melanoma's high propensity to metastasize to the brain and the resulting poor prognosis, there is a crucial need to better understand the molecular mechanisms that allow melanoma cells to metastasize and survive in the brain and identify potential theranostic cell-surface markers. CD44 glycoproteins, a family of cell-surface adhesion molecules, are key receptors of hyaluronic acid (HA), which is one of the most important components of the extracellular matrix with a high concentration in brain tissue (Ananthanarayanan et al., 2011; Aruffo et al., 1990). Activation of CD44 by HA leads to an enhanced migration of melanoma and other tumor cells (Ichikawa et al., 1999). "
    [Show abstract] [Hide abstract]
    ABSTRACT: Melanoma brain metastasis (MBM) is frequent and has a very poor prognosis with no current predictive factors or therapeutic molecular targets. Our study unravels the molecular alterations of cell-surface glycoprotein CD44 variants during melanoma progression to MBM. High expression of CD44 splicing variant 6 (CD44v6) in primary melanoma (PRM) and regional lymph node metastases from AJCC Stage IIIC patients significantly predicts MBM-development. The expression of CD44v6 also enhances the migration of MBM cells by hyaluronic acid and hepatocyte growth factor exposure. Additionally, CD44v6-positive MBM migration is reduced by blocking with CD44v6-specific monoclonal antibody or knocking down CD44v6 by siRNA. ESRP1 and ESRP2 splicing factors correlate with CD44v6 expression in PRM, and ESRP1 knockdown significantly decreases CD44v6 expression. However, an epigenetic silencing of ESRP1 is observed in metastatic melanoma, specifically in MBM. In advanced melanomas, CD44v6 expression is correlated with PTBP1 and U2AF2 splicing factors, and we found that PTBP1 knockdown also significantly decreases CD44v6 expression. Overall, these findings open up a new avenue for understanding the high affinity of melanoma to MBM, suggesting CD44v6 as a potential MBM-specific factor with theranostic utility for stratifying patients.This article is protected by copyright. All rights reserved.
    Pigment Cell & Melanoma Research 08/2014; 28(1). DOI:10.1111/pcmr.12307 · 4.62 Impact Factor
  • Source
    • "While it has long been understood that many tumors, including GBM, are mechanically stiffer than the surrounding stroma [4], [5], it has only recently become appreciated that these mechanical aberrations may actively instruct malignant progression rather than simply being a passive manifestation of tumor growth [6]–[8]. For example, we previously demonstrated that GBM cells show higher proliferation and migration rates when cultured on stiff two-dimensional substrates [9], [10]. Consistent with this idea, GBM tumors and culture models often display altered expression of molecules known to play key roles in sensing and/or responding to mechanical signals encoded in the tissue microenvironment (i.e., mechanosensing). "
    [Show abstract] [Hide abstract]
    ABSTRACT: The aggressive and rapidly lethal brain tumor glioblastoma (GBM) is associated with profound tissue stiffening and genomic lesions in key members of the epidermal growth factor receptor (EGFR) pathway. Previous studies from our laboratory have shown that increasing microenvironmental stiffness in culture can strongly enhance glioma cell behaviors relevant to tumor progression, including proliferation, yet it has remained unclear whether stiffness and EGFR regulate proliferation through common or independent signaling mechanisms. Here we test the hypothesis that microenvironmental stiffness regulates cell cycle progression and proliferation in GBM tumor cells by altering EGFR-dependent signaling. We began by performing an unbiased reverse phase protein array screen, which revealed that stiffness modulates expression and phosphorylation of a broad range of signals relevant to proliferation, including members of the EGFR pathway. We subsequently found that culturing human GBM tumor cells on progressively stiffer culture substrates both dramatically increases proliferation and facilitates passage through the G1/S checkpoint of the cell cycle, consistent with an EGFR-dependent process. Western Blots showed that increasing microenvironmental stiffness enhances the expression and phosphorylation of EGFR and its downstream effector Akt. Pharmacological loss-of-function studies revealed that the stiffness-sensitivity of proliferation is strongly blunted by inhibition of EGFR, Akt, or PI3 kinase. Finally, we observed that stiffness strongly regulates EGFR clustering, with phosphorylated EGFR condensing into vinculin-positive focal adhesions on stiff substrates and dispersing as microenvironmental stiffness falls to physiological levels. Our findings collectively support a model in which tissue stiffening promotes GBM proliferation by spatially and biochemically amplifying EGFR signaling.
    PLoS ONE 07/2014; 9(7):e101771. DOI:10.1371/journal.pone.0101771 · 3.23 Impact Factor
Show more